Company Registration No. 11659157 (England and Wales)
PORTESS MEDICAL WRITING LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
7 Christie Way
Manchester
United Kingdom
M21 7QY
PORTESS MEDICAL WRITING LTD
CONTENTS
Page
Company information
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
PORTESS MEDICAL WRITING LTD
BALANCE SHEET
AS AT
30 NOVEMBER 2025
30 November 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
5,222
4,263
Current assets
Debtors
4
115,773
90,318
Cash at bank and in hand
129,785
791,728
245,558
882,046
Creditors: amounts falling due within one year
5
(82,638)
(59,913)
Net current assets
162,920
822,133
Total assets less current liabilities
168,142
826,396
Provisions for liabilities
(1,306)
(1,066)
Net assets
166,836
825,330
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
166,835
825,329
Total equity
166,836
825,330

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

PORTESS MEDICAL WRITING LTD
BALANCE SHEET (CONTINUED)
AS AT
30 NOVEMBER 2025
30 November 2025
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 23 April 2026
Mr Dan Portess
Director
Company registration number 11659157 (England and Wales)
PORTESS MEDICAL WRITING LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 3 -
1
Accounting policies
Company information

Portess Medical Writing Ltd is a private company limited by shares incorporated in England and Wales. The registered office is , 7 Christie Way, Manchester, United Kingdom, M21 7QY.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover isreduced for estimated customer returns, rebates and other similar allowances.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
20% Reducing Balance
Computers
20% Reducing Balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

PORTESS MEDICAL WRITING LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

PORTESS MEDICAL WRITING LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

PORTESS MEDICAL WRITING LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 6 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Tangible fixed assets
Fixtures and fittings
Computers
Total
£
£
£
Cost
At 1 December 2024
250
7,988
8,238
Additions
1,225
745
1,970
At 30 November 2025
1,475
8,733
10,208
Depreciation and impairment
At 1 December 2024
183
3,792
3,975
Depreciation charged in the year
95
916
1,011
At 30 November 2025
278
4,708
4,986
Carrying amount
At 30 November 2025
1,197
4,025
5,222
At 30 November 2024
67
4,196
4,263
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
56,532
20,622
Other debtors
59,241
69,696
115,773
90,318
PORTESS MEDICAL WRITING LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 7 -
5
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
6,567
5,911
Corporation tax
70,496
49,571
Other taxation and social security
3,297
2,891
Other creditors
2,278
1,540
82,638
59,913
2025-11-30 2024-12-01 false false false 23 April 2026 CCH Software CCH Accounts Production 2026.200 No description of principal activity Mr Dan Portess 11659157 2024-12-01 2025-11-30 11659157 2025-11-30 11659157 2024-11-30 11659157 core:FurnitureFittings 2025-11-30 11659157 core:ComputerEquipment 2025-11-30 11659157 core:FurnitureFittings 2024-11-30 11659157 core:ComputerEquipment 2024-11-30 11659157 core:WithinOneYear 2025-11-30 11659157 core:WithinOneYear 2024-11-30 11659157 core:CurrentFinancialInstruments core:WithinOneYear 2025-11-30 11659157 core:CurrentFinancialInstruments core:WithinOneYear 2024-11-30 11659157 core:ShareCapital 2025-11-30 11659157 core:ShareCapital 2024-11-30 11659157 core:RetainedEarningsAccumulatedLosses 2025-11-30 11659157 core:RetainedEarningsAccumulatedLosses 2024-11-30 11659157 bus:Director1 2024-12-01 2025-11-30 11659157 core:FurnitureFittings 2024-12-01 2025-11-30 11659157 core:ComputerEquipment 2024-12-01 2025-11-30 11659157 2023-12-01 2024-11-30 11659157 core:FurnitureFittings 2024-11-30 11659157 core:ComputerEquipment 2024-11-30 11659157 2024-11-30 11659157 core:CurrentFinancialInstruments 2025-11-30 11659157 core:CurrentFinancialInstruments 2024-11-30 11659157 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 11659157 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 11659157 bus:FRS102 2024-12-01 2025-11-30 11659157 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 11659157 bus:FullAccounts 2024-12-01 2025-11-30 xbrli:pure xbrli:shares iso4217:GBP